Overview

Quadruple and Phytomedicine-based Therapies in H. Pylori Infection

Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
Helicobacter pylori is strongly associated to the development of gastrointestinal disorders. Emerging antibiotic resistance and poor patient compliance of modern therapies has resulted in significant eradication failure. Clinical trial was conducted to see the efficacy of current quadruple and phytomedicine-based therapies for the eradication of H. pylori infection and relief in its associated symptoms in Pakistan.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Hafiz Muhammad Asif
Treatments:
Amoxicillin
Bismuth
Bismuth tripotassium dicitrate
Ranitidine
Ranitidine bismuth citrate